reglab/statecodes huggingface dataset:
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.05 - Application Review

Current through Register Vol. 51, No. 14, July 12, 2024
A. The burden of
				  proving an applicant's qualifications rests on the applicant
B. The Commission may deny an application
				  that contains a misstatement, omission, misrepresentation, or
				  untruth.
C. An application shall be
				  complete in every material detail.
D. The Commission may request any additional
				  information the Commission determines is necessary to process and fully
				  investigate an application.
E. The
				  applicant shall provide requested additional information by the close of
				  business of the 14th business day after the request has been received by the
				  applicant.
F. If the applicant does
				  not provide the requested information within 14 business days, the Commission
				  may consider the application to be suspended.
G. The Commission intends to award the
				  licenses to the best applications that most efficiently and effectively ensure
				  public safety and safe access to medical cannabis.
H. The Commission shall provide guidelines
				  and detailed instructions for submitting the application form for the
				  Commission's consideration.
I. The
				  Commission, or a Commission independent contractor, shall review for a
				  pre-approval for a license the submitted applications as described in
				  Regulations .02B and .05E of this chapter. The applications shall be ranked
				  based on the following weighted criteria:
(1)
				  Operational factors will be afforded 20 percent weight, including:
(a) A detailed operational plan for the
				  cultivation of medical cannabis; and
(b) Summaries of policies and procedures for:
(i) Cultivation;
(ii) Growth;
(iii) Processing; and
(iv) Packaging;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.06 - Pre-Approval of License Application

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  Commission may issue pre-approval of up to 22 licenses
B. If there are more qualified applications
				  than the number of licenses available and there is a numerical tie for the last
				  license to be issued, the license shall be determined by public
				  lottery.
C. The Commission may deny
				  issuing a pre-approval of a license if any individual identified in the
				  application specified in Regulation .02B(1) of this chapter:
(1) Is convicted of or pleads nolo contendere
				  to a crime involving moral turpitude, whether or not any appeal or other
				  proceeding is pending to have the conviction or plea set aside;
(2) Is in arrears on taxes due in any
				  jurisdiction ; or
(3) Fraudulently
				  or deceptively attempts to obtain a license.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.07 - Issuance of License

Current through Register Vol. 51, No. 14, July 12, 2024
A. After an
				  applicant has been issued a pre-approval for a license under this chapter the
				  applicant shall submit to the Commission, as part of its application:
(1) An audited financial statement for the
				  applicant and any proposed grower agents; and
(2) Payment of the stage 2 application fee
				  specified in COMAR 10.62.35
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.08 - Transfer of Ownership Interest in a License

Current through Register Vol. 51, No. 14, July 12, 2024
A. No ownership
				  interest shall be assignable or transferable unless:
(1) The Commission has received notice of the
				  intent of the owner of the interest, or of the estate of the owner of the
				  interest, to transfer or assign an ownership interest in a license to another
				  party;
(2) The Commission approves
				  the transfer or assignment;
(3) The
				  transferee has paid the required fee specified in COMAR 10.62.35; and
(4) If the ownership interest is 5 percent
				  or more, the transferee has provided the criminal history record information
				  and an audited financial statement to the Commission of the
				  transferee
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.09 - Change of Location

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensee may apply to change the location of the licensee's
				  operation.
B. The licensee shall
				  submit an application to the Commission along with the fee specified in COMAR
				  10.62.35.
C. A licensee may not
				  begin cultivation or dispensing of medical cannabis at a new location until all
				  inspections have been passed.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.10 - Renewal of License

Current through Register Vol. 51, No. 14, July 12, 2024
A. A medical
				  cannabis grower license is valid for:
(1) 6
				  years on initial licensure; and
(2)
				  4 years on renewal.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.11 - Annual Report on Minority Owners and Employees

Current through Register Vol. 51, No. 14, July 12, 2024
On June 1 of each year, each licensee shall submit a report
					 in a manner determined by the Commission regarding the licensee's minority
					 owners and employees.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.12 - Disclosure of Ownership and Control

Current through Register Vol. 51, No. 14, July 12, 2024
A. Each
				  licensee shall submit a table of organization, ownership, and control with the
				  Commission:
(1) On or before July 1 of each
				  year;
(2) Within 10 business days
				  of any change in ownership interest or control; and
(3) Upon request by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.13 - Management Agreements

Current through Register Vol. 51, No. 14, July 12, 2024
A. Prior
				  to any management agreement taking effect, a licensee shall submit to the
				  Commission:
(1) A copy of the management
				  agreement;
(2) Information
				  detailing any compensation paid in exchange for the management
				  services;
(3) Criminal history
				  record information and an audited financial statement of the third party
				  providing the management services; and
(4) Any other information relevant to the
				  management agreement requested by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.08 - Medical Cannabis Grower License › Section 10.62.08.14 - Mandatory Reporting of Legal Actions

Current through Register Vol. 51, No. 14, July 12, 2024
A. The required
				  reporting under this regulation applies to any owner or manager of a licensee
				  or its parent, affiliate, or subsidiary who is or was a party to the legal
				  action whether in Maryland or another jurisdiction.
B. Notification.
(1) An owner or manager described in §A
				  of this regulation shall notify and provide a description to the Commission of
				  any of the following events:
(a) The filing of
				  any administrative, civil, or criminal action against the licensee or its
				  parent, affiliate, or subsidiary by any governmental entity, private entity, or
				  individual;
(b) The disposition of
				  any administrative, civil, or criminal action against the licensee or its
				  parent, affiliate, or subsidiary by any governmental entity, private entity, or
				  individual, whether by judgment, final order, consent order, or other
				  negotiated resolution; or
(c) The
				  filing for bankruptcy of the licensee or its parent, affiliate, or subsidiary,
				  the entry of a court order for placement into receivership, or the date of an
				  assignment for the benefit of creditors.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.01 - Definition

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meaning indicated.
B. Terms Defined
(1) "License" means a license issued by the
				  Commission to operate as a licensed grower.
(2) "Licensee" means a licensed
				  grower.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.02 - Grower Agent Generally

Current through Register Vol. 51, No. 14, July 12, 2024
A grower agent shall be 21 years old or older.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.03 - Grower Agent Registration and Criminal History Record

Current through Register Vol. 51, No. 14, July 12, 2024
A. Each medical cannabis grower agent shall
				  be registered with the Commission before the agent may volunteer or work for a
				  licensed grower.
B. A licensed
				  grower shall apply to register a grower agent by submitting to the Commission:
(1) The name, address, date of birth, and
				  Social Security Number of a grower agent;
(2) Documentation of the submission of
				  fingerprints of the grower agent to the Central Registry; and
(3) The request for the criminal history
				  record information of the grower agent to be forwarded to the
				  Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.04 - Registered Grower Agent Identification Cards

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Commission shall issue to each
				  registered grower agent a identification card which includes a photograph of
				  the face of the registered grower agent taken no more than 6 months before the
				  date of the application.
B. At all
				  times every registered grower agent at a licensed premises shall visibly wear
				  the identification card issued to the registered grower agent by the
				  Commission.
C. The identification
				  card shall be renewed every 2 years.
D. If a registered grower agent's
				  identification card is lost, destroyed or stolen, within 24 hours of becoming
				  aware of the loss, destruction or theft, the licensee shall:
(1) Report the loss, destruction or theft to
				  the Commission;
(2) Apply for a
				  replacement card; and
(3) Pay a
				  replacement card fee specified in COMAR 10.62.35.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.05 - Termination

Current through Register Vol. 51, No. 14, July 12, 2024
A. As soon as
				  possible upon termination of a registered grower agent's association with a
				  licensed grower, the licensed grower shall:
(1) Take custody of a terminated registered
				  grower agent's identification card;
(2) Obtain any keys or other entry devices
				  from a terminated registered grower agent; and
(3) Ensure a terminated registered grower
				  agent can no longer gain access to the licensed premises.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.06 - Prospective Grower Agent Drug Screen

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  licensee shall require a prospective grower agent to submit to a drug screen
				  before commencement of association.
B. The drug screen shall be carried out
				  following the procedures set forth in COMAR 17.04.09.04-.08.
C. In addition to the drugs to be screened in
				  accordance with COMAR
				  17.04.09.06, the screen shall
				  include any other drugs as required by the Commission.
D. Unless medically justified, a prospective
				  grower agent who has a positive response to any tested substance on a drug
				  screen that meets the requirements of COMAR
				  17.04.09.07 may not be registered
				  by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.07 - Grower Agent Training

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  licensee shall train all registered grower agents on:
(1) Federal and State medical cannabis laws
				  and regulations and other laws and regulations pertinent to the grower agent's
				  responsibilities;
(2) Standard
				  operating procedures;
(3) Detection
				  and prevention of diversion of medical cannabis;
(4) Security procedures; and
(5) Safety procedures, including responding
				  to;
(a) A medical emergency;
(b) A fire;
(c) A chemical spill; and
(d) A threatening event such as:
(i) An armed robbery;
(ii) An invasion;
(iii) A burglary; or
(iv) Any other criminal incident.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.08 - Alcohol and Drug Free Workplace Policy

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Each registered grower agent shall declare in writing that the registered
				  grower agent will adhere to the State alcohol and drug free workplace policy,
				  as identified in COMAR 21.11.08.03.
B. The licensee shall retain the declaration
				  in a registered grower agent's personnel record.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.09 - Medical Cannabis Grower Agent › Section 10.62.09.09 - Annual Verification of Registered Grower Agents

Current through Register Vol. 51, No. 14, July 12, 2024
Every year, on a date determined by the Commission, the
					 licensee shall notify the Commission that the licensee has verified that no
					 registered grower agent has been convicted of a felony drug
					 offense.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meaning indicated.
B. Terms Defined.
(1) "License" means a license issued by the
				  Commission to operate as a grower.
(2) "Licensee" means a licensed
				  grower.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.02 - Premises Generally

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensed premises shall be located within Maryland,
B. The premises and operations of a licensee
				  shall conform to local zoning and planning requirements.
C. The grower license shall be conspicuously
				  displayed at each licensed premises.
D. Modification of Premises.
(1) No major renovation or modification to a licensed
				  premises shall be undertaken without prior approval from the
				  Commission.
(2) The Commission
				  shall approve the renovation or modification upon a determination that the
				  licensed grower passes an on-site inspection that ensures the proposed premises
				  conform to the requirements of this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.03 - Additional Provisions for Field or Greenhouse Cultivation Premises

Current through Register Vol. 51, No. 14, July 12, 2024
A. Licensed premises for field cultivation of
				  medical cannabis shall be situated to maintain the greatest achievable level of
				  privacy and security.
B. Physical
				  Security. An area of cultivation shall be securely surrounded by fencing and
				  gates constructed to prevent unauthorized entry.
C. Fencing and gates shall be equipped with a
				  security alarm system that:
(1) Covers the
				  entire perimeter;
(2) Is
				  continuously monitored; and
(3) Is
				  capable of detecting power loss.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.04 - Security of Premises

Current through Register Vol. 51, No. 14, July 12, 2024
A licensed premises shall be constructed to prevent
					 unauthorized entry.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.05 - Security Lighting

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Lighting fixtures of the licensed grower shall be designed and installed to
				  ensure proper surveillance.
B.
				  This regulation does not apply to lighting in areas of the premises used to
				  cultivate medical cannabis.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.06 - Security Alarm Systems

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensee shall maintain a security alarm system that covers all perimeter entry
				  points and portals at all premises.
B. A security system shall be:
(1) Continuously monitored;
(2) Capable of detecting smoke and fire; and
(3) Capable of detecting power
				  loss.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.07 - Video Surveillance Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensee shall maintain a motion-activated video surveillance recording system
				  at all premises that:
(1) Records all
				  activity in images of high quality and high resolution capable of clearly
				  revealing facial detail;
(2)
				  Operates 24-hours a day, 365 days a year without interruption; and
(3) Provides a date and time stamp for every
				  recorded frame.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.10 - Medical Cannabis Grower Premises › Section 10.62.10.08 - Visitor to a Non-Public Area of the Premises

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  When a visitor is admitted to a non-public area of the premises of a licensee,
				  a registered grower agent shall:
(1) Log the
				  visitor in and out;
(2) Retain
				  with the log a photocopy of the visitor's government issued
				  identification;
(3) Continuously
				  visually supervise the visitor while on the premises; and
(4) Ensure that the visitor does not touch
				  any plant or medical cannabis.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.11 - Medical Cannabis Growing Controls › Section 10.62.11.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Green waste" means unused, surplus,
				  returned or out of date medical cannabis, recalled medical cannabis, and any
				  plant debris, including dead plants, all unused plant parts, and
				  roots.
(2) "Growing media" means
				  commercially produced potting mix or hydroponic solution or any other substrate
				  used for growing.
(3) "License"
				  means a license issued by the Commission to operate as a licensed
				  grower.
(4) "Licensee" means a
				  licensed grower
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.11 - Medical Cannabis Growing Controls › Section 10.62.11.02 - Standard Operating Procedures

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensee
				  shall establish written standard operating procedures to promote good growing
				  and handling practices including:
(1) All
				  aspects of the:
(a) Irrigation, propagation,
				  cultivation, fertilization;
(b)
				  Harvesting, drying, curing;
(c)
				  Rework or reprocessing;
(d)
				  Packaging, labeling and handling of medical cannabis products, byproduct;
				  and
(e) Waste products, and the
				  control thereof to promote good growing and handling
				  practices;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.11 - Medical Cannabis Growing Controls › Section 10.62.11.03 - Horticultural Controls

Current through Register Vol. 51, No. 14, July 12, 2024
A. Water.
				  The licensee shall keep a record of water quality testing on site and make it
				  available for inspection.
B.
				  Fertilizer. As part of the standard operating procedure, a licensee shall:
(1) Adopt a nutrient management plan prepared
				  by a certified nutrient management consultant;
(2) Use fertilizer or hydroponic solution of
				  a type, formulation, and at a rate, to support healthy growth of medical
				  cannabis; and
(3) Maintain records
				  of the type and amounts of fertilizer and any growth additives used.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.11 - Medical Cannabis Growing Controls › Section 10.62.11.04 - Equipment

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensee
				  shall maintain equipment that comes in contact with medical cannabis to prevent
				  contamination.
B. A licensee shall
				  maintain cleaning and equipment maintenance logs.
C. A licensee shall have any scale, balance,
				  or other measurement device, and any automatic, mechanical, or electronic
				  equipment:
(1) Annually calibrated by a
				  calibration laboratory accredited to International Organization for
				  Standardization (ISO) standard 17025 ISO/IEC by an accreditation body that is a
				  signatory to the International Laboratory Accreditation Cooperation (ILAC)
				  Mutual Recognition Arrangement; and
(2) Checked at least once per month to ensure
				  accuracy.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Inventory control" means the record of
				  the inventory in the perpetual inventory control system used by the licensee in
				  accordance with this chapter;
(2)
				  "Licensee" means a licensed grower.
(3) "Unique identifier" means any symbol or
				  mark which will enable tracking of medical cannabis from plant to final product
				  by means of the inventory control.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.02 - Inventory Control System

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensee
				  shall enter timely and accurate data into a perpetual inventory control system
				  that identifies and tracks the licensee's stock of medical cannabis from the
				  time the medical cannabis is propagated from seed or cutting to the time it is
				  delivered to a licensed dispensary, a licensed processor, or a qualifying
				  patient or caregiver.
B. In the
				  event of a serious adverse event, an inventory control system shall be capable
				  of tracking medical cannabis from a qualifying patient back to the source of
				  medical cannabis.
C. The inventory
				  control system shall be designed to promptly identify a discrepancy in the
				  stocks.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.03 - Materials Received for Cultivation

Current through Register Vol. 51, No. 14, July 12, 2024
Upon receipt of raw material for cultivation, a licensee
					 shall record in the inventory control:
A. The date delivered; and
B. The number of cuttings or seeds delivered
				  or the weight of the seeds for each variety in the shipment.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.04 - Plant Tagging and Entry into Inventory Control

Current through Register Vol. 51, No. 14, July 12, 2024
A. For each plant, as soon as practical, a
				  licensee shall:
(1) Create a unique
				  identifier for each plant;
(2)
				  Assign each plant to a batch;
(3)
				  Enter information regarding the plant into the inventory control
				  system;
(4) Create a tag with the
				  unique identifier and batch number; and
(5) Securely attach the tag to a plant
				  container or plant.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.05 - Control of Harvested Medical Cannabis

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee shall:
A. Upon completion of curing or drying of
				  each batch, weigh medical cannabis to update inventory control for the batch;
				  and
B. At least monthly, conduct a
				  physical inventory of the stock and compare the physical inventory of stock
				  with inventory control.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.06 - Discrepancy Reporting

Current through Register Vol. 51, No. 14, July 12, 2024
A. If a
				  licensee discerns a discrepancy between the inventory of stock and inventory
				  control outside of normal weight loss due to moisture loss and handling, the
				  licensee shall commence an investigation of the discrepancy within 1 business
				  day.
B. If the licensee finds
				  evidence of a theft or diversion within 1 business day, the licensee shall
				  report the theft or diversion to the:
(1)
				  Commission; and
(2) Law enforcement
				  agency with jurisdiction in the licensee's area.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.07 - Product Returned for Destruction

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee shall accept the return of any medical cannabis
					 from a qualifying patient or a caregiver to destroy.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.08 - Bar on Distribution of Non-Complying Medical Cannabis

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensee or registered grower agent may
				  not distribute any medical cannabis to any person if the licensee or registered
				  grower agent knows, or may have reason to know, that the distribution does not
				  comply with any provision of the Health -General Article, Title 13, Subtitle
				  33, Annotated Code of Maryland or this subtitle.
B. A licensee or registered grower agent may
				  not distribute any medical cannabis to any person if the licensee or registered
				  grower agent knows, or may have reason to know, that the medical cannabis does
				  not comply with any provision of the Health - General Article, Title 13,
				  Subtitle 33, Annotated Code of Maryland or this subtitle.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.12 - Inventory Control by Grower › Section 10.62.12.09 - Theft or Diversion

Current through Register Vol. 51, No. 14, July 12, 2024
A. If the
				  licensee finds evidence of a theft or diversion, the licensee shall report the
				  theft or diversion to the Commission and to the law enforcement agency with
				  jurisdiction in the licensee's area within 1 business day.
B. Within 30 business days of discovering the
				  theft or diversion, the licensee shall:
(1)
				  Complete an investigation;
(2)
				  Amend the licensee's standard operating procedures, if necessary; and
(3) Send a report of the investigation to the
				  Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.13 - Medical Cannabis Shipment Packaging › Section 10.62.13.01 - Packaging Products Containing Medical Cannabis for Shipment

Current through Register Vol. 51, No. 14, July 12, 2024
A. Before shipping an order of products
				  containing medical cannabis, a licensee shall, if necessary, repackage the
				  shipment into a container:
(1) Constructed of
				  tamper-evident opaque material; and
(2) Sealed with tamper-evident
				  tape.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.13 - Medical Cannabis Shipment Packaging › Section 10.62.13.02 - Labeling of Packages for Shipment

Current through Register Vol. 51, No. 14, July 12, 2024
A. Each
				  package in a shipment of products containing cannabis shall be labeled with:
(1) The date and time of the sealing of the
				  package for shipment;
(2) The name
				  and signature of the registered grower agent, registered processor agent, or
				  registered dispensary agent who prepared the package and sealed the
				  package;
(3) The name and address
				  of the shipping licensee;
(4) The
				  shipment identification number;
(5)
				  A description, including the weight, of each item, contained in the package;
				  and
(6) The name and address of the
				  licensee, or other party if applicable, to receive the shipment.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.14 - Licensed Grower Dispensary Facility › Section 10.62.14.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Licensed grower dispensary facility"
				  means a facility where a licensed grower may dispense medical
				  cannabis.
(2) "Licensee" means a
				  licensed grower.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.14 - Licensed Grower Dispensary Facility › Section 10.62.14.02 - Licensed Grower Dispensary Facility

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  A licensee may dispense medical cannabis to qualifying patients and caregivers
				  in conformity with COMAR 10.62.25 - 10.62.31 at a facility for which the
				  licensee has obtained a license to dispense medical cannabis.
B. A licensed grower dispensary facility
				  shall be constructed and operated in conformity to COMAR 10.62.27, relating to
				  medical cannabis dispensary premises.
C. A licensee may hire employees or use
				  volunteers at a licensed grower dispensary facility in conformity to COMAR
				  10.62.26.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.01 - Production and Process Controls

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensed grower shall cultivate each plant and produce each batch of medical
				  cannabis in conformity with the standard operating procedures.
B. A licensed grower shall record the
				  cultivation process in accordance to standard operating procedures to ensure:
(1) Consistency of the batch with the
				  variety; and
(2) Accuracy of the
				  day-to-day production.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.02 - In-Process Inspection by Grower

Current through Register Vol. 51, No. 14, July 12, 2024
During the process of cultivation, a licensed grower shall
					 regularly inspect each plant to ensure proper growth and absence of pests and
					 disease.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.03 - Holding Procedure

Current through Register Vol. 51, No. 14, July 12, 2024
A licensed grower shall hold medical cannabis in secure,
					 segregated storage until released for distribution.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.04 - Independent Testing Laboratory Selection

Current through Register Vol. 51, No. 14, July 12, 2024
A licensed grower shall use an independent testing
					 laboratory:
A. That has adopted a
				  standard operating procedure to test medical cannabis and medical cannabis
				  concentrate that is approved by an accreditation body that is a signatory to
				  the International Laboratory Accreditation Cooperation (ILAC) Mutual
				  Recognition Arrangement;
B. To
				  obtain samples of each batch according to a statistically valid sampling method
				  by an agent of an independent testing laboratory;
C. To analyze the samples according to:
(1) The most current version of the cannabis
				  inflorescence monograph published by the American Herbal Pharmacopeia (AHP);
				  or
(2) A scientifically valid
				  methodology that is equal or superior to that of the AHP monograph;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.05 - Contents of Certificate of Analysis

Current through Register Vol. 51, No. 14, July 12, 2024
An independent testing laboratory shall issue to the
					 licensed grower a certificate of analysis for each batch, with supporting data,
					 to report:
A. The concentrations of
				  the following compounds:
(1) [DELTA]
				  9-Tetrahydrocannabinol (THC);
(2)
				  Tetrahydrocannabinolic Acid (THCA);
(3) Cannabidiol (CBD);
(4) Cannabidiolic Acid (CBDA); and
(5) The terpenes described in the most
				  current version of the cannabis inflorescence monograph published by the
				  American Herbal Pharmacopeia (AHP);
(6) Cannabigerol (CBG); and
(7) Cannabinol (CBN); and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.06 - Grower Determination That a Batch May be Released

Current through Register Vol. 51, No. 14, July 12, 2024
A. If a licensed grower, upon review of the
				  certificate of analysis, determines that a batch meets the specification for
				  the variety, the licensed grower may:
(1)
				  Assign an expiration date to the batch;
(2) Release the batch for distribution;
				  and
(3) Revise the status of the
				  batch in the inventory control.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.15 - Medical Cannabis Grower Quality Control › Section 10.62.15.07 - Stability Testing and Retention Sampling

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  A licensed grower shall provide a sample from each released batch to an
				  independent testing laboratory sufficient to perform stability testing at
				  6-month intervals to:
(1) Ensure product
				  potency and purity; and
(2) Provide
				  support for expiration dating.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.16 - Independent Testing Laboratory Registration › Section 10.62.16.01 - Definition

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following term have the meaning indicated.
B. Terms Defined.
(1) "Accreditation body" means a nonprofit,
				  impartial organization that requires conformance to 17025 ISO/IEC requirements
				  and is a signatory to the International Laboratory Accreditation Cooperation
				  (ILAC) Mutual Recognition Arrangement for Testing.
(2) "Certificate of accreditation" means a
				  certificate issued by an accrediting body for the independent testing
				  laboratory facility, entity or site to be registered in Maryland.
(3) "Independent testing laboratory" means
				  any facility, entity, or site in Maryland that offers or performs tests of
				  medical cannabis or products containing medical cannabis and is independent of
				  any entity that grows, processes or dispenses cannabis.
(4) "Scope of accreditation" means a document
				  issued by the accreditation body which describes the methodologies, range, and
				  parameters for testing medical cannabis or products containing medical cannabis
				  for which the accreditation has been granted.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.16 - Independent Testing Laboratory Registration › Section 10.62.16.02 - Registration

Current through Register Vol. 51, No. 14, July 12, 2024
A. An
				  independent testing laboratory shall register with the Commission.
B. To register, an independent laboratory
				  shall:
(1) Submit a completed independent
				  laboratory registration form;
(2)
				  Pay the registration fee specified in COMAR
				  10.62.35.01.
(3) Submit a copy of the certificate of
				  accreditation accompanied by the scope of accreditation; and
(4) Submit the name, address, date of birth
				  and Social Security Number of each independent testing laboratory employee and
				  a copy of the application form completed by each independent testing laboratory
				  employee.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.16 - Independent Testing Laboratory Registration › Section 10.62.16.03 - Standards of Care

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  independent testing laboratory shall follow the methodologies, ranges, and
				  parameters which are contained in the scope of the accreditation for testing
				  medical cannabis or products containing medical cannabis.
B. The independent testing laboratory shall
				  require each independent testing laboratory employee to complete and execute an
				  application for employment on a form provided by the Commission.
C. The independent testing laboratory shall
				  establish and follow written procedures for verifying the experience and
				  education of laboratory employees.
D. The independent testing laboratory shall
				  submit the registration information for each independent testing laboratory
				  employee within 15 days after the date the independent testing laboratory
				  employee was hired.
E. Upon
				  termination of the association of the registered independent testing laboratory
				  employee with the independent testing laboratory, the independent testing
				  laboratory shall:
(1) Obtain any keys or
				  other entry devices from the terminated independent testing laboratory
				  employee;
(2) Ensure the terminated
				  independent laboratory employee can no longer gain access to the laboratory
				  premises; and
(3) Within 1 business
				  day of the termination of independent laboratory employee, the independent
				  testing laboratory shall notify the Commission of the termination.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.16 - Independent Testing Laboratory Registration › Section 10.62.16.04 - Term and Renewal

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  registration is valid for 2 years.
B. The registration may be renewed by
				  submitting to the Commission:
(1) A copy of
				  the independent testing laboratory registration form;
(2) Payment of the registration fee specified
				  in COMAR 10.62.35; and
(3)
				  Submission of copies of the most recent:
(a)
				  Assessment from the accreditation body; and
(b) Periodic review of the proficiency
				  testing of the results obtained by the independent testing
				  laboratory.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.16 - Independent Testing Laboratory Registration › Section 10.62.16.05 - Independent Testing Laboratory Responsibilities

Current through Register Vol. 51, No. 14, July 12, 2024
No independent testing laboratory may handle, test, or
					 analyze cannabis or cannabis products unless the independent testing
					 laboratory:
A. Has been registered by
				  the Commission;
B. Is independent
				  from all other persons and entities involved in the medical cannabis
				  industry;
C. Is accredited by an
				  accreditation body or has a provisional registration from the Commission;
				  and
D. Has established standard
				  operating procedures that provide for adequate chain of custody controls for
				  samples transferred to the independent testing laboratory for
				  testing.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.16 - Independent Testing Laboratory Registration › Section 10.62.16.06 - Transportation of Products Containing Medical Cannabis

Current through Register Vol. 51, No. 14, July 12, 2024
A. A registered independent testing
				  laboratory may transport samples of medical cannabis and products containing
				  medical cannabis from the premises of a licensed grower, processor, or
				  dispensary to the independent testing laboratory.
B. A registered independent laboratory shall
				  transport samples of medical cannabis and products containing medical cannabis:
(1) With oversight by at least one
				  independent testing laboratory employee registered with the Commission;
				  and
(2) Using a vehicle that:
(a) Meets the criteria specified in COMAR
				  10.62.18.05 and .06; and
(b) Is registered with the
				  Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.17 - Complaints, Adverse Events, and Recall › Section 10.62.17.01 - Receipt and Documentation of Complaints and Adverse Events

Current through Register Vol. 51, No. 14, July 12, 2024
A licensed grower, licensed processor, licensed dispensary,
					 certifying provider, and the Commission shall establish a procedure to receive,
					 organize, store and respond to all oral, written, electronic or other
					 complaints regarding medical cannabis and adverse events.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.17 - Complaints, Adverse Events, and Recall › Section 10.62.17.02 - Report of Serious Adverse Event to Commission and Interested Parties

Current through Register Vol. 51, No. 14, July 12, 2024
In the event a complaint associated with a serious adverse
					 event is received, a licensee, or certifying provider, shall within 24 hours
					 report the complaint to:
A. The
				  Commission;
B. The licensed grower
				  from which the medical cannabis originated and, if applicable, the licensed
				  processor from which the medical cannabis finished product originated;
				  and
C. The certifying provider
				  caring for the qualifying patient.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.17 - Complaints, Adverse Events, and Recall › Section 10.62.17.03 - Complaint Investigation by Grower or Dispensary

Current through Register Vol. 51, No. 14, July 12, 2024
A. Whenever a complaint regarding the quality
				  or safety of medical cannabis is received by a licensed grower, licensed
				  processor, or licensed dispensary, a licensee shall, within 24 hours
(1) Report the complaint to the Commission in
				  order for the Commission to determine if the complaint is substantive or a
				  serious adverse event;
(2)
				  Promptly determine the batch number or lot number of the medical cannabis, the
				  medical cannabis-infused product, medical cannabis concentrate, edible cannabis
				  product, or any other product that is the subject of the complaint;
				  and
(3) Investigate the record and
				  circumstances of the production of the batch or lot to determine if:
(a) There was a deviation from the standard
				  operating procedure in the production of the batch or lot by reviewing
				  production logs;
(b) The sample
				  meets quality and safety standards by submitting parts of the retention samples
				  of the batch or lot to an independent testing laboratory; and
(c) There is reasonable cause to suspect
				  communicable disease transmission and, if so, collect morbidity history from
				  any suspected agents.